Patent 9694100 was granted and assigned to Smith & Nephew on July, 2017 by the United States Patent and Trademark Office.
The present invention is directed to topical enzymatic wound debriding compositions with enhanced enzymatic activity. These compositions comprise a dispersed phase comprising at least one proteolytic enzyme and at least one hydrophilic polyol; and a continuous phase comprising a hydrophobic base.